By Alex Sirois
Publication Date: 2026-08-07 04:42:00
Quick Read
IBM’s rebound from post-earnings lows remains contested, as a securities fraud inquiry and execution cracks counter its $24.6 billion recurring software business.
IBM trades at a forward P/E of 19, yields 2.86% backed by 31 consecutive increases, and sits 20% below where it started 2025.
A Buy trigger requires software growth near 10%, mainframe recovery, and fraud inquiry closure, but none of those conditions are expected to arrive before the Q3 earnings report.
It sounds nuts, but SoFi1 is giving new Active Invest users up to $3,000 in stock for a limited time, and all it takes is a $50 deposit to get started.2 See for yourself (Sponsor)
At $233.43, IBM (NYSE:IBM) sits in an unresolved setup. The stock has rebounded 10.6% from its post-earnings low of $211.15, but the setup remains too contested to justify conviction in either direction.
IBM is…
